We have recently reported that transcription factor 8 (TCF8) negatively regulates pathological angiogenesis by regulating endothelial invasiveness by acting as a transcriptional attenuator of matrix metalloproteinase 1. TCF8 also modulates cell-matrix and cell-cell adhesion; however molecular mechanism of this TCF8 function remains obscure. Here, we provide evidence that TCF8 activates R-Ras, another class of angiogenic regulator, to suppress angiogenesis by a mechanism other than a transcriptional attenuator.
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Introduction
The two-handed zinc finger (ZF) homeodomain transcription factor TCF8, alternatively designated as EF1, ZEB-1, Nil2, AREB6, and Zfhxp1, has been implicated in a variety of biological phenomena, including cancer invasion, cellular senescence, viral infection, bone metabolism, T-cell and neuronal development, as well as pathological responses of blood vessels [1] [2] [3] [4] [5] [6] . Most of these functions are ascribed to the transcriptional attenuation via the two ZFdomain clusters of TCF8; however, knowledge about the other function than transcriptional regulation is currently limited.
R-Ras, a member of Ras family of GTP-binding proteins, is originally isolated by lowstringency hybridization with a v-H-ras probe [7] . Apart from the similarity to the functions of classical Ras, such as the activation of the extracellular signal-regulated kinase/mitogenactivated protein kinase cascade [8] , R-Ras seems to have its unique functions: stimulating cell adhesion by integrin [9] , inhibiting apoptosis [10] , and regulation of exocytosis [11] . However, so far, no specific effector molecules for R-Ras have been reported to explain its different (distinct) functions. Recently, R-Ras is implicated in pathological angiogenesis [12, 13] , although mechanism of the specific participation of this molecule is yet to be determined.
Recently, we have reported that TCF8, of which expression is induced in endothelial cells during angiogenesis, negatively regulates tumor angiogenesis via transcriptional attenuation of matrix metalloprotease (MMP)-1, and via the augmentation of cell-matrix and cell-cell adhesion. However, molecular mechanism by which TCF8 regulates cell adhesiveness remains obscure.
Here, we show that TCF8 activates R-Ras and provide evidence that the activation is due to the direct binding of TCF8 to CalDAG-GEFIII, an activator of R-Ras, but not transcriptional regulation of the R-Ras regulators. Our finding may explain how the TCF8-R-Ras axis specifically plays a role in pathological angiogenesis.
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Materials and Methods
Reagents and antibodies. Antibodies against TCF8 (ZEB1), HA, R-Ras, Flag were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), Roche (Indianapolis, IN), Cell Signaling Technology (Beverly, MA), Stratagene (La Jolla, CA) respectively. The rabbit antiserum raised against CalDAG-GEFIII was kindly provided by Dr. M. Matsuda (Kyoto Univ., Kyoto, Japan).
Expression plasmids. Human TCF8 cDNA was obtained by RT-PCR of total RNA from HUVECs and was cloned into pCR-BluntII-TOPO (Invitrogen, Carlsbad, CA). To generate Flagor HA-tagged TCF8 expression vectors, the cDNA was subcloned into the XhoI and NotI sites of the pCXN2-Flag or pCXN2-3xHA vectors [14] . A series of expression vectors for TCF8 deletion mutants were constructed as above after PCR amplification with specific primers. All constructs were confirmed by sequencing analysis. pCXN2-Flag-R-Ras WT and pCXN2-Flag-CalDAG-GEFI, II, and III were described previously [15] . The expression vectors for TCF8-CFP and YFP-CalDAGIII were generated as described above using pCXN2-Flag-CFPC and pCXN2- Pull-down assay for R-Ras. Detection of GTP-bound R-Ras was performed essentially as described previously [18] . Briefly, cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM MgCl 2 , 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and 1 mM Na 3 VO 4 ), clarified by centrifugation, and incubated with GST-RalGDS-RBD for 30 min. The resulting complexes of GTP-bound R-Ras and GST-RalGDS-RBD were precipitated with glutathione-Sepharose beads, washed twice with lysis buffer, and eluted. GTP-bound R-Ras was detected by immunoblotting.
RNA isolation and RT-PCR.
RNA isolation and quantitative RT-PCR were performed as described previously [6, 19] . The primers used for PCR amplification are listed in Supplementary Table. Data were normalized by the expression level of GAPDH in each sample.
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Fluorescence microscopy. Immunofluorescence microscopy and intermolecular FRET analysis were performed as described [20, 21] .
Tube formation assay. Tube formation by HUVECs on Matrigel (BD-Discovery
Labware, Bedford, MA) was performed as described previously [22, 23] with some modifications. Each well of a 48-well plate was coated with 125 l of 10 mg/ml Matrigel, and was filled with 2 × 10 4 cells in 500 l of complete EGM-2. At the indicated times, ten images of the formed tubes were obtained for every well and the number of tubes was quantified.
Statistical analyses. All data represent means and SD of experiments performed in triplicate, and were subjected to one-way analysis of variance, followed by the comparison by Student's t-tests. P values obtained from the tests are described in the figure legends.
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Results and Discussion
We first tested whether TCF8 is involved in R-Ras signaling. R-Ras activity in the quiescent human umbilical endothelial cells (HUVECs) is lower than the detectable level and the effect of TCF8 knockdown on R-Ras activation could not be observed (data not shown);
however, cell adhesion-induced R-Ras activation was substantially inhibited in TCF8-silenced HUVECs (Fig. 1A) . Conversely, overexpression of TCF8 dramatically activated R-Ras in 293T cells (Fig. 1B) . Next, the functional importance of R-Ras as the effector of TCF8 was examined by utilizing lentivirus-mediated gene transfer [17] , which yields sufficient protein expression with approximately 70% transfection efficiency in HUVECs (Fig. 1C) . Expression of R-Ras V38, the constitutive active mutant of R-Ras, attenuated the enhanced tube formation obtained with TCF8-suppressed HUVECs ( Fig. 1D and E). These data thereby indicate that TCF8 mediates RRas signaling in the negative regulation of angiogenesis.
Next, to explore the detailed mechanism through which TCF8 regulates R-Ras, we generated deletion mutants of TCF8 ( Fig. 2A) , and found that TCF8-HDCZF and TCF8-CZF, but not TCF8-NZF or TCF8-HD, activated R-Ras, suggesting that a cluster of C-terminal ZF domains is essential for R-Ras activation (Fig. 2B) . Since the C-terminal ZF domains are required for the canonical function of TCF8 to bind to the E2-box sequence CACCTG on target genes and to regulate their transcription [24] , we examined the effect of TCF8 on mRNA levels of R-Ras regulators, including guanine nucleotide exchange factors (GEFs) and GTPaseactivating proteins (GAPs). RT-PCR revealed no significant differences in the expression of these proteins, which would reflect R-Ras activation by TCF8 (Fig. 2C) . Essentially similar results were obtained when we used 293T cells (Fig. 2D) . This is an unexpected result because most previous works have shown the significance of transcriptional attenuation of target genes in the explanation of the phenotypes obtained. Although, of course, TCF8 can be involved in the transcriptional regulation of other class of regulators than GEFs and GAPs, it is possible that TCF8 activates R-Ras by different mechanism from transcriptional attenuator.
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During the course of experiments to examine the effect of TCF8 on the mRNA expression of GEFs and GAPs in Fig. 2 , we noticed that, of the calcium-and diacylglycerol (DAG)-responding GEFs, CalDAG-GEFIII was preferentially expressed in HUVECs, as was previously reported [25] . Therefore, we hypothesized that TCF8 mediates CalDAG-GEFIII activation by the direct interaction. For this purpose, we utilized antiserum specific for CalDAG-GEFIII (Fig. 3A) to determine whether TCF8 bound to CalDAG-GEFIII. Coimmunoprecipitation analysis revealed an interaction between endogenous TCF8 and CalDAG-GEFIII in HUVECs (Fig. 3B) . In addition, co-expression of TCF8 and CalDAGIII achieved an additive effect on R-Ras activation (Fig. 3C ). Localization studies of TCF8 and its truncated mutants revealed that R-Ras-activating proteins, TCF8-FL, TCF8-HDCZF, and TCF8-CZF, localized to both the nucleus and the cytoplasm, whereas the proteins lacking the ability to activate R-Ras, TCF8-NZF and TCF8-HD, were restrictively localized in the nucleus and at the plasma membrane, respectively (Fig. 3D) . Furthermore, the interaction of TCF8 and CalDAGIII was observed in the cytoplasm by fluorescence resonance energy transfer (FRET) (Fig. 3E) .
Although the exact mechanism of how TCF8 activates CalDAGIII remains obscure, we provide evidence for a novel function for TCF8 in the cytoplasm, beyond transcriptional regulation.
In the present study, we show that TCF8 activates R-Ras though the distinct function than transcription attenuator. The pull-down analysis using the truncated mutants revealed that the Cterminal ZF domains of TCF8 are required for R-Ras activation (Fig. 2B) . Furthermore, the localization studies revealed that the proteins activating R-Ras resided in, and are bound to CalDAGIII in the cytosol ( Fig. 3D and E) , suggesting a novel cytoplasmic function for TCF8.
Interestingly, it was previously reported that mice lacking the 728-1124 aa that include the Cterminal ZF domains of TCF8 can survive, unlike mice deficient in full length TCF8 [4] . With respect to the importance of these C-terminal ZF domains in the activation of R-Ras, it is noteworthy that R-Ras KO mice are healthy under normal conditions [12] , suggesting that the molecular mechanism involved in developmental stages are quite distinct from those needed for 9/15 pathological angiogenesis, which apparently requires the TCF8 C-terminal ZF domains and downstream R-Ras activation [6, 12] .
The communication between endothelial cells and ECMs is crucial for angiogenesis [22, 26] , which are attenuated in TCF8-repressed HUVECs [6] . The depletion of TCF8 significantly hampers cell adhesion-induced activation of R-Ras (Fig. 1A) . Therefore, R-Ras can participate in the TCF8 mediated signaling pathway to cell-matrix adhesion, and subsequent angiogenesis ( Fig.   1D and E) . The presented data here may provide novel acceptable regulatory mechanism to explain R-Ras specific function. Furthermore, our findings on the restricted expression pattern of TCF8 within tumor vessels [6] may therefore account for the specific implication of R-Ras in the negative regulation of pathological angiogenesis [12] . 
